CommercialCoverageMedium impact
06.02.39d, Measurement of Serum Antibodies to and Measurement of Serum Levels of Biologics
Independence Blue Cross·Allergy & Immunology, Gastroenterology, Rheumatology +3 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Policy 06.02.39d addresses measurement of serum antibodies to and serum levels of biologics. This is a reissue effective 10/01/2025. Without access to the full policy text content, the specific billing code changes, coverage determinations, and clinical requirements cannot be definitively extracted. The billing team must obtain and review the complete policy document to identify which CPT/HCPCS codes are affected, what prior authorization requirements apply, and how reimbursement has changed.
Action Required
By September 30, 2025: Billing team must obtain the full text of policy 06.02.39d from the source URL (https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=10&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-06-02-39d) and review all specific CPT/HCPCS codes, coverage rules, and prior authorization requirements. Identify any changes from the previous version of this policy. Update billing software, encounter forms, and provider education materials accordingly. Schedule staff training on new requirements before October 1, 2025, effective date. Failure to implement changes may result in claim denials for serum antibody and biologic level testing services.